Oxford BioMedica (LSE:OXB) Total Liabilities : £173.75 Mil (As of Jun. 2024)

View and export this data going back to 2001. Start your Free Trial

What is Oxford BioMedica Total Liabilities?

Oxford BioMedica's Total Liabilities for the quarter that ended in Jun. 2024 was £173.75 Mil.

Oxford BioMedica's quarterly Total Liabilities declined from Jun. 2023 (£202.91 Mil) to Dec. 2023 (£174.51 Mil) and declined from Dec. 2023 (£174.51 Mil) to Jun. 2024 (£173.75 Mil).

Oxford BioMedica's annual Total Liabilities increased from Dec. 2021 (£49.89 Mil) to Dec. 2022 (£223.99 Mil) but then declined from Dec. 2022 (£223.99 Mil) to Dec. 2023 (£174.51 Mil).

Oxford BioMedica Total Liabilities Historical Data

The historical data trend for Oxford BioMedica's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oxford BioMedica Total Liabilities Chart

Oxford BioMedica Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

47.30

71.18

49.89

223.99

174.51

Oxford BioMedica Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Total Liabilities	Get a 7-Day Free Trial															206.69	223.99	202.91	174.51	173.75

Oxford BioMedica Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Oxford BioMedica's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	44.315	+	(107.804	+	22.389
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	174.51

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	252.342	-	77.834
	=	174.51

Oxford BioMedica's Total Liabilities for the quarter that ended in Jun. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	59.149	+	(105.49	+	9.112
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	173.75

Total Liabilities	=	Total Assets (Q: Jun. 2024 )	-	Total Equity (Q: Jun. 2024 )
	=	244.971	-	71.22
	=	173.75

Oxford BioMedica Total Liabilities Related Terms

Thank you for viewing the detailed overview of Oxford BioMedica's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Oxford BioMedica Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oxford BioMedica PLC (LSE:OXB) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

OXBDF:USA OXBl:UK OXO:Germany OXOA:Germany

Address

Windrush Court, Transport Way, Oxford, GBR, OX4 6LT

Website

https://www.oxb.com

Oxford BioMedica PLC is a contract development and manufacturing organization (CDMO) focused on cell and gene therapy. The company specializes in viral vector development and manufacturing for cell and gene therapy, with expertise in lentivirus, adeno-associated virus (AAV), adenovirus and other viral vector types.

Oxford BioMedica Headlines

No Headlines